Zhen Huang
Director/Board Member at WALVAX BIOTECHNOLOGY CO., LTD.
Net worth: 57 M $ as of 31/05/2024
Zhen Huang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Director/Board Member | 22/08/2019 | - |
| Corporate Officer/Principal | 01/01/2003 | 22/08/2019 | |
| Yuxi Walvax Biotechnology Co., Ltd. | President | - | - |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
Career history of Zhen Huang
Statistics
International
| China | 4 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Zhen Huang
- Experience
